Presented by Thomas Imperiale at the ASGE Joint Panel: Endoscopic Management of Colon Lesions held during the 2017 SAGES Annual Meeting in Houston, TX on Saturday, March 25, 2017
Keyword(s): African Americans, alcohol, American College of Gastroenterology, American College of Physicians, analysis, aspirin, barium enema, BMI, body mass index, bowel prep, colon, colon capsule, colonoscopy, colorectal cancer, cost effectiveness, CRC, CT colonography, demographics, diagnostic, diet, endoscopic colorectal cancer screening, estrogen, FAP, FDA, fecal occult blood, FIT testing, flex sig, flexible sigmoidoscopy, FOB, guaiac test, guidelines, high risk, incidence, Lancet, male, mortality, neoplasia, NSAID, polyp, quality assurance, randomized trials, reimbursement, resource utilization, screening, sedation, sigmoidoscopy, smoking, stool DNA test, therapeutic, training, U.S. Preventative Task Force
U.S. & Canadian recommendations–45 sec
When to begin screening–2:52
CRC screening tests–4:20
Which test for which patient?–5:07
Citation–5:46 JAMA 2016
Colonoscopy pros & cons–7:17
Sigmoidoscopy pros & cons–8:32
Citation–10:51 GIE 2007
Prediction rules for CRC screening–11:14
Risk factors for CRC–11:34
Candidate factors for estimating risk–11:59
Risk of advanced neoplasia–14:19 Ann Intern Med 2015
Summary–15:41